Leg restlessness preceding the onset of motor symptoms of Parkinson disease: A case series of 5 patients.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 16 8 2019
pubmed: 16 8 2019
medline: 4 9 2019
Statut: ppublish

Résumé

Patients with Parkinson disease (PD) often show restless legs syndrome (RLS), leg motor restlessness (LMR) and other leg restlessness (OLR) related to sensorimotor symptoms.Here, we describe 5 patients who presented with leg restlessness as an early manifestation of PD.In case 1, the patient had leg restlessness that was not LMR or RLS and preceded the onset of motor symptoms by 1 year. In case 2, LMR preceded motor symptoms by 2 years. Case 3 had unilateral RLS symptoms on the left side of the body for 33 years. Two and a half years after the spread of RLS symptoms to the right leg with increased frequency of left-sided RLS symptoms, the patient developed PD at the age of 58 years. In cases 4 and 5, RLS symptoms preceded motor symptoms by 3 months and 1 month, respectively. All patients developed Parkinsonism within 3 years (median, 1.0 year; range 0.083-2.5 years) after initial onset or exacerbation of leg restlessness. All patients had frequent leg restlessness symptoms (6-7 days per week). In our series, the preceding leg restlessness was unilateral and confined to the dominant side of the subsequent Parkinsonism, or preceding leg restlessness was bilateral but dominant on the dominant side of the subsequent Parkinsonism.Clinicians should be aware that late-onset leg restlessness (>50 years of age) including RLS, LMR, and OLR, particularly if frequent and asymmetrical, can be an early nonmotor manifestation of PD.

Identifiants

pubmed: 31415433
doi: 10.1097/MD.0000000000016892
pii: 00005792-201908160-00087
pmc: PMC6831196
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16892

Références

Sleep Med Rev. 2018 Oct;41:101-112
pubmed: 29449121
J Neural Transm (Vienna). 2019 Apr;126(4):423-431
pubmed: 29943229
Eur J Neurol. 2012 Mar;19(3):411-6
pubmed: 21978091
Arch Intern Med. 2005 Jun 13;165(11):1286-92
pubmed: 15956009
Mov Disord. 2006 Mar;21(3):380-4
pubmed: 16211604
Chem Senses. 2006 May;31(4):379-91
pubmed: 16527871
J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S3-13
pubmed: 24858728
Curr Neurol Neurosci Rep. 2015 Mar;15(3):8
pubmed: 25687697
J Neurol Sci. 2012 Jul 15;318(1-2):76-81
pubmed: 22534309
Mov Disord Clin Pract. 2014 Sep 1;1(3):200-212
pubmed: 25328906
Arch Neurol. 2002 Mar;59(3):421-4
pubmed: 11890847
Sci Rep. 2017 Sep 5;7(1):10547
pubmed: 28874701
Sleep Med. 2009 May;10(5):556-65
pubmed: 18824408
J Neurol Sci. 2012 Sep 15;320(1-2):26-31
pubmed: 22704032
Mov Disord. 2010 Nov 15;25(15):2654-7
pubmed: 20737545
Neurology. 2011 Nov 29;77(22):1941-6
pubmed: 22076542
Parkinsonism Relat Disord. 2016 Mar;24:28-33
pubmed: 26842545
Sleep Med. 2014 Aug;15(8):860-73
pubmed: 25023924
Int J Neurosci. 2015;125(7):526-30
pubmed: 25405536
J Neurol Sci. 2018 Oct 15;393:51-57
pubmed: 30103064
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Eur J Neurol. 2019 Jul;26(7):979-985
pubmed: 30706593
J Neurol Sci. 2017 Apr 15;375:80-85
pubmed: 28320195
Parkinsonism Relat Disord. 2018 Jun;51:117-118
pubmed: 29506822
Sleep Med. 2011 Oct;12(9):821-6
pubmed: 22001218
PLoS One. 2016 Nov 3;11(11):e0165869
pubmed: 27812167
Nat Rev Neurol. 2016 Oct 27;12(11):622-634
pubmed: 27786242
Nat Rev Neurol. 2010 Jun;6(6):337-46
pubmed: 20531433
Sleep. 2014 Feb 01;37(2):369-72
pubmed: 24497665
J Neurol Sci. 2018 Nov 15;394:41-44
pubmed: 30212740
Lancet Neurol. 2008 Nov;7(11):1044-55
pubmed: 18940694
Intern Med. 2017 Nov 1;56(21):2871-2878
pubmed: 28943542
Mov Disord. 2007;22 Suppl 18:S424-30
pubmed: 17534950
Sleep. 2016 Feb 01;39(2):405-12
pubmed: 26564123
Rinsho Shinkeigaku. 2018 Oct 24;58(10):617-621
pubmed: 30270336
Tremor Other Hyperkinet Mov (N Y). 2013 Oct 07;3:
pubmed: 24255803

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH